VRAX logo

VRAX EBIT

Annual EBIT

-$6.71 M
-$1.27 M-23.33%

March 1, 2024


Summary


Performance

VRAX EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVRAXprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

VRAX EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-23.3%--
3 y3 years-941.8%--
5 y5 years-934.6%--

VRAX EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-941.8%at low
5 y5-year-941.8%at low
alltimeall time-941.8%at low

Virax Biolabs Group Limited EBIT History

DateAnnualQuarterlyTTM
Mar 2024
-$6.71 M(+23.3%)
-
-
Mar 2023
-$5.44 M(+213.8%)
-
-
DateAnnualQuarterlyTTM
Mar 2022
-$1.73 M(+169.2%)
-
-
Mar 2021
-$644.30 K(-0.7%)
-
-
Mar 2020
-$648.80 K
-
-

FAQ

  • What is Virax Biolabs Group Limited annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Virax Biolabs Group Limited?
  • What is Virax Biolabs Group Limited annual EBIT year-on-year change?

What is Virax Biolabs Group Limited annual earnings before interest & taxes?

The current annual EBIT of VRAX is -$6.71 M

What is the all time high annual EBIT for Virax Biolabs Group Limited?

Virax Biolabs Group Limited all-time high annual earnings before interest & taxes is -$644.30 K

What is Virax Biolabs Group Limited annual EBIT year-on-year change?

Over the past year, VRAX annual earnings before interest & taxes has changed by -$1.27 M (-23.33%)